These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30061692)

  • 1. Magnetic Drug Targeting: A Novel Treatment for Intramedullary Spinal Cord Tumors.
    Kheirkhah P; Denyer S; Bhimani AD; Arnone GD; Esfahani DR; Aguilar T; Zakrzewski J; Venugopal I; Habib N; Gallia GL; Linninger A; Charbel FT; Mehta AI
    Sci Rep; 2018 Jul; 8(1):11417. PubMed ID: 30061692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intramedullary spinal cord tumors: a review of current and future treatment strategies.
    Tobin MK; Geraghty JR; Engelhard HH; Linninger AA; Mehta AI
    Neurosurg Focus; 2015 Aug; 39(2):E14. PubMed ID: 26235012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive Imaging of Liposomal Delivery of Superparamagnetic Iron Oxide Nanoparticles to Orthotopic Human Breast Tumor in Mice.
    Kato Y; Zhu W; Backer MV; Neoh CC; Hapuarachchige S; Sarkar SK; Backer JM; Artemov D
    Pharm Res; 2015 Nov; 32(11):3746-3755. PubMed ID: 26078000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of superparamagnetic iron oxide nanoparticles for magnetically guided drug delivery.
    Kumar P; Agnihotri S; Roy I
    Int J Nanomedicine; 2018; 13(T-NANO 2014 Abstracts):43-46. PubMed ID: 30880956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implant-Assisted Intrathecal Magnetic Drug Targeting to Aid in Therapeutic Nanoparticle Localization for Potential Treatment of Central Nervous System Disorders.
    Lueshen E; Venugopal I; Soni T; Alaraj A; Linninger A
    J Biomed Nanotechnol; 2015 Feb; 11(2):253-61. PubMed ID: 26349301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and characterization of bacteriochlorin loaded magnetic nanoparticles (MNP) for personalized MRI guided photosensitizers delivery to tumor.
    Ostroverkhov PV; Semkina AS; Naumenko VA; Plotnikova EA; Melnikov PA; Abakumova TO; Yakubovskaya RI; Mironov AF; Vodopyanov SS; Abakumov AM; Majouga AG; Grin MA; Chekhonin VP; Abakumov MA
    J Colloid Interface Sci; 2019 Mar; 537():132-141. PubMed ID: 30439612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal magnetic drug targeting using gold-coated magnetite nanoparticles in a human spine model.
    Lueshen E; Venugopal I; Kanikunnel J; Soni T; Alaraj A; Linninger A
    Nanomedicine (Lond); 2014; 9(8):1155-69. PubMed ID: 23862614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer.
    Zhou H; Qian W; Uckun FM; Wang L; Wang YA; Chen H; Kooby D; Yu Q; Lipowska M; Staley CA; Mao H; Yang L
    ACS Nano; 2015 Aug; 9(8):7976-91. PubMed ID: 26242412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneous dimer peptide-conjugated polylysine dendrimer-Fe
    Shen JM; Li XX; Fan LL; Zhou X; Han JM; Jia MK; Wu LF; Zhang XX; Chen J
    Int J Nanomedicine; 2017; 12():1183-1200. PubMed ID: 28243083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and in vitro and in vivo evaluations of poly(ethylene glycol)-block-poly(4-vinylbenzylphosphonate) magnetic nanoparticles containing doxorubicin as a potential targeted drug delivery system.
    Hałupka-Bryl M; Asai K; Thangavel S; Bednarowicz M; Krzyminiewski R; Nagasaki Y
    Colloids Surf B Biointerfaces; 2014 Jun; 118():140-7. PubMed ID: 24769390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin loaded magnetic gold nanoparticles for in vivo targeted drug delivery.
    Elbialy NS; Fathy MM; Khalil WM
    Int J Pharm; 2015 Jul; 490(1-2):190-9. PubMed ID: 25997662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theranostic Application of Mixed Gold and Superparamagnetic Iron Oxide Nanoparticle Micelles in Glioblastoma Multiforme.
    Sun L; Joh DY; Al-Zaki A; Stangl M; Murty S; Davis JJ; Baumann BC; Alonso-Basanta M; Kaol GD; Tsourkas A; Dorsey JF
    J Biomed Nanotechnol; 2016 Feb; 12(2):347-56. PubMed ID: 27305768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programmed near-infrared light-responsive drug delivery system for combined magnetic tumor-targeting magnetic resonance imaging and chemo-phototherapy.
    Feng Q; Zhang Y; Zhang W; Hao Y; Wang Y; Zhang H; Hou L; Zhang Z
    Acta Biomater; 2017 Feb; 49():402-413. PubMed ID: 27890732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal magnetic drug targeting for localized delivery of therapeutics in the CNS.
    Venugopal I; Habib N; Linninger A
    Nanomedicine (Lond); 2017 Apr; 12(8):865-877. PubMed ID: 28339319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient VEGF targeting delivery of DOX using Bevacizumab conjugated SiO
    Zhu R; Wang Z; Liang P; He X; Zhuang X; Huang R; Wang M; Wang Q; Qian Y; Wang S
    Acta Biomater; 2017 Nov; 63():163-180. PubMed ID: 28923539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-delivery of Doxorubicin and D-α-Tocopherol Polyethylene Glycol 1000 Succinate by Magnetic Nanoparticles.
    Metin E; Mutlu P; Gündüz U
    Anticancer Agents Med Chem; 2018; 18(8):1138-1147. PubMed ID: 29532763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic drug targeting in a rhabdomyosarcoma rat model using magnetite-dextran composite nanoparticle-bound mitoxantrone and 0.6 tesla extracorporeal magnets - sarcoma treatment in progress.
    Krukemeyer MG; Krenn V; Jakobs M; Wagner W
    J Drug Target; 2012 Feb; 20(2):185-93. PubMed ID: 22044194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro anti-cancer efficacy of multi-functionalized magnetite nanoparticles combining alternating magnetic hyperthermia in glioblastoma cancer cells.
    Minaei SE; Khoei S; Khoee S; Vafashoar F; Mahabadi VP
    Mater Sci Eng C Mater Biol Appl; 2019 Aug; 101():575-587. PubMed ID: 31029351
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Zhang Y; Ji W; He L; Chen Y; Ding X; Sun Y; Hu S; Yang H; Huang W; Zhang Y; Liu F; Xia L
    Theranostics; 2018; 8(6):1690-1705. PubMed ID: 29556350
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of liposome-containing SPIONs conjugated with anti-CD20 developed as a novel theranostic agent for central nervous system lymphoma.
    Saesoo S; Sathornsumetee S; Anekwiang P; Treetidnipa C; Thuwajit P; Bunthot S; Maneeprakorn W; Maurizi L; Hofmann H; Rungsardthong RU; Saengkrit N
    Colloids Surf B Biointerfaces; 2018 Jan; 161():497-507. PubMed ID: 29128836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.